Now that Atossa Therapeutics Inc’s volume has hit 0.87 million, investors get a glimpse of its size.

NFTs Stocks

Atossa Therapeutics Inc (NASDAQ: ATOS) on Monday, soared 5.80% from the previous trading day, before settling in for the closing price of $0.94. Within the past 52 weeks, ATOS’s price has moved between $0.59 and $1.39.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

The company achieved an average annual earnings per share of -14.29%. With a float of $125.28 million, this company’s outstanding shares have now reached $126.62 million.

Atossa Therapeutics Inc (ATOS) Insider Updates

Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Atossa Therapeutics Inc is 0.02%, while institutional ownership is 19.48%. The most recent insider transaction that took place on Nov 15, was worth 32,500. In this transaction Former EVP, CFO, & Director of this company sold 50,000 shares at a rate of $0.65, taking the stock ownership to the 55 shares.

Atossa Therapeutics Inc (ATOS) Performance Highlights and Predictions

As on 9/29/2023, Multinational firm has announced its last quarter scores, in which it reported -$0.05 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.07) by $0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -14.29% per share during the next fiscal year.

Atossa Therapeutics Inc (NASDAQ: ATOS) Trading Performance Indicators

Atossa Therapeutics Inc (ATOS) is currently performing well based on its current performance indicators. A quick ratio of 28.35 was reported for the most recent quarter.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.24, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.26 in one year’s time.

Technical Analysis of Atossa Therapeutics Inc (ATOS)

The latest stats from [Atossa Therapeutics Inc, ATOS] show that its last 5-days average volume of 0.51 million was superior to 0.39 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 72.95%. Additionally, its Average True Range was 0.05.

During the past 100 days, Atossa Therapeutics Inc’s (ATOS) raw stochastic average was set at 77.08%, which indicates a significant decrease from 78.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 50.39% in the past 14 days, which was lower than the 57.20% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $0.8325, while its 200-day Moving Average is $0.8486. Now, the first resistance to watch is $1.0433. This is followed by the second major resistance level at $1.0966. The third major resistance level sits at $1.1432. If the price goes on to break the first support level at $0.9434, it is likely to go to the next support level at $0.8968. Assuming the price breaks the second support level, the third support level stands at $0.8435.

Atossa Therapeutics Inc (NASDAQ: ATOS) Key Stats

Market capitalization of the company is 124.05 million based on 125,304K outstanding shares. Right now, sales total 0 K and income totals -26,960 K. The company made 0 K in profit during its latest quarter, and -6,230 K in sales during its previous quarter.